ALCOHOL DRINKING IN RATS IS ATTENUATED BY THE MIXED 5-HT1 AGONIST 5-HT2 ANTAGONIST FG 5893

被引:25
|
作者
SINGH, GK
KALMUS, GW
BJORK, AK
MYERS, RD
机构
[1] E CAROLINA UNIV,SCH MED,DEPT PHARMACOL,GREENVILLE,NC 27858
[2] E CAROLINA UNIV,SCH MED,DEPT PSYCHIAT MED,GREENVILLE,NC 27858
[3] E CAROLINA UNIV,DEPT BIOL,GREENVILLE,NC 27858
[4] KABI PHARMACIA AB,BUSINESS UNIT CNS,MALMO,SWEDEN
关键词
ALCOHOL DRINKING; SEROTONIN; BRAIN; ETHANOL INTAKE; ALCOHOL PREFERENCE; DOPAMINERGIC SYSTEMS; MESOLIMBIC SYSTEM; 5-HT2; RECEPTORS; ALCOHOLISM; 5-HT1A RECEPTORS;
D O I
10.1016/0741-8329(93)90043-N
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Over the last three decades, the neurotransmitter serotonin (5-HT) has been implicated in the etiological mechanisms underlying the excessive drinking of ethyl alcohol. Recently, the 5-HT2 antagonist amperozide was found to reduce selectively the high intake of alcohol in the cyanamide-induced drinking rat without any adverse side effects. The purpose of the present study was to determine the action on alcohol drinking of the novel second-generation amperozide-like drug, which is a mixed 5-HT1 agonist/5-HT2 antagonist, FG 5893 (2-[4-[4,4-bis(4-fluorophenyl)butyl]-l-piperazinyl]-3-pyridinecarboxylic acid methyl ester). To induce preference for alcohol in Sprague-Dawley rats, the enzyme aldehyde dehydrogenase was inhibited by cyanamide administered in the absence of alcohol in a dose of 10 mg/kg twice a day over three days. A standard three-bottle preference test was used in which water and a maximally preferred concentration of alcohol were offered to each animal. Following control tests of alcohol preference for 3 days, either a saline control vehicle or FG 5893 in a dose of 0.5, 1.0, or 2.5 mg/kg was administered subcutaneously at 1600 and 2200 for 3 consecutive days. Whereas control injections of saline were without effect on alcohol consumption, all doses of FG 5893 significantly reduced the 24-h intake of alcohol in terms of both absolute g/kg and proportion of alcohol to total fluid intake. Further, the 1.0 and 2.5 mg/kg doses of FG 5893 continued to suppress alcohol consumption over two 4-day tests immediately following the injection sequence and after a 40-day interval. Neither body weights nor intakes of food of the rats were affected by FG 5893 either during or after its administration. Thus, it is proposed that this putative anxiolytic and antidepressant drug causes a prolonged modification in the function of serotonergic synapses in the mesolimbic system of the brain. Because FG 5893 possesses combined 5-HT1A agonist and 5-HT2 antagonist characteristics, it is envisaged that the addictive property of alcohol may in part involve a concurrent perturbation in the function of these two subtypes of scrotonergic receptors.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [1] Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist 5-HT2 antagonist
    Long, TA
    Kalmus, GW
    Bjork, A
    Myers, RD
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (01) : 33 - 40
  • [2] Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors
    Watson, J
    Brough, S
    Coldwell, MC
    Gager, T
    Ho, M
    Hunter, AJ
    Jerman, J
    Middlemiss, DN
    Riley, GJ
    Brown, AM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) : 1413 - 1420
  • [3] CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES INDUCED BY 5-HT1 AND 5-HT2 AGONISTS IN RATS
    ARNT, J
    PHARMACOLOGY & TOXICOLOGY, 1989, 64 (02): : 165 - 172
  • [4] FAILURE OF THE 5-HT2 RECEPTOR ANTAGONIST, RITANSERIN, TO ALTER PREFERENCE FOR ALCOHOL IN DRINKING RATS
    MYERS, RD
    LANKFORD, MF
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (01) : 233 - 237
  • [5] 5-HT1 AND 5-HT2 BINDING CHARACTERISTICS OF SOME QUIPAZINE ANALOGS
    GLENNON, RA
    SLUSHER, RM
    LYON, RA
    TITELER, M
    MCKENNEY, JD
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (11) : 2375 - 2380
  • [6] Involvement of 5-HT1 and 5-HT2 receptor in regulation of methamphetamine self-administration in rats
    Novakova, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S420 - S420
  • [7] CEREBRAL CORTICAL 5-HT1 AND 5-HT2 RECEPTORS OF MORPHINE TOLERANT-DEPENDENT RATS
    GULATI, A
    BHARGAVA, HN
    NEUROPHARMACOLOGY, 1988, 27 (12) : 1231 - 1237
  • [8] Limited access to ethanol in genetic drinking rats is suppressed while feeding is enhanced by the mixed 5-HT1A agonist 5-HT2A antagonist FG5938
    West, MW
    Kalmus, G
    Myers, RD
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (04) : 823 - 828
  • [9] EFFECT OF CHRONIC TREATMENT WITH 5-HT1 AGONIST (8-OH-DPAT AND RU24969) AND ANTAGONIST (ISAPIRONE) DRUGS ON THE BEHAVIORAL-RESPONSES OF MICE TO 5-HT1 AND 5-HT2 AGONISTS
    DESOUZA, RJ
    GOODWIN, GM
    GREEN, AR
    HEAL, DJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (02) : 377 - 384
  • [10] Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors
    Ng, NK
    Lee, HS
    Wong, PTH
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 55 (05) : 600 - 607